Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radio therapeutic agent for Gastrin Releasing Peptide receptor positive tumors

被引：39
|
作者：
Chen, Jianqing [1 ]
Linder, Karen E. [1 ]
Cagnolini, Aldo [1 ]
Metcalfe, Edmund [1 ]
Raju, Natarajan [1 ]
Tweedle, Michael F. [1 ]
Swenson, Rolf E. [1 ]
机构：
[1] Bracco Res USA Inc, Princeton, NJ 08540 USA
来源：
APPLIED RADIATION AND ISOTOPES | 2008年 / 66卷 / 04期
关键词：
Lu-177-AMBA; bombesin; gastrin releasing peptide; targeted radiotherapy; radiolysis protection;
D O I：
10.1016/j.apradiso.2007.11.007
中图分类号：
O61 [无机化学];
学科分类号：
070301 ; 081704 ;
摘要：
A robust formulation was developed for [Lu-177]Lu-AMBA (Lu-177-DO3A-CH2CO-G-[4-aminobenzoyl]-QWAVGHLM-NH2), a Bombesin-like agonist with high affinity for Gastrin Releasing Peptide (GRP) receptors. During optimization of labeling, the effect of several radiostabilizers was evaluated; a combination of selenomethionine and ascorbic acid showed superiority over other tested radiostabilizers. The resulting two-vial formulation maintains a radiochemical purity (RCP) of >90% for at least 2 days at room temperature. The method of stabilization should be useful for other methionine-containing peptide radiopharmaceuticals in diagnostic and therapeutic applications. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：497 / 505
页数：9
相关论文
共 47 条
  • [31] The Influence of Early Measurements Onto the Estimated Kidney Dose in [177Lu][DOTA0,Tyr3]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine Tumors
    Delker, Andreas
    Ilhan, Harun
    Zach, Christian
    Brosch, Julia
    Gildehaus, Franz Josef
    Lehner, Sebastian
    Bartenstein, Peter
    Boning, Guido
    MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (05) : 726 - 734
  • [32] Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Adults with Inoperable or Metastatic Somatostatin Receptor-Positive Pheochromocytomas/Paragangliomas, Bronchial and Unknown Origin Neuroendocrine Tumors, and Medullary Thyroid Carcinoma: A Systematic Literature Review
    Hertelendi, Marianna
    Belguenani, Oulaya
    Cherfi, Azzeddine
    Folitar, Ilya
    Kollar, Gabor
    Polack, Berna Degirmenci
    BIOMEDICINES, 2023, 11 (04)
  • [33] Diagnostic versus therapeutic doses of [177Lu-DOTA-Tyr3]-octreotate:: Uptake and dosimetry in somatostatin receptor-positive tumors and normal organs
    Muller, Cristina
    Forrer, Flavio
    Bernard, Bert F.
    Melis, Marleen
    Konijnenberg, Mark
    Krenning, Eric P.
    de Jong, Marion
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (01) : 151 - 159
  • [34] Trial in progress: Evaluation of the safety, tolerability, whole-body distribution, radiation dosimetry and antitumor activity of 177Lu-NeoB in patients with advanced solid tumors expressing gastrin-releasing peptide receptor (GRPR)
    Mittra, Erik
    Iagaru, Andrei
    Van der Veldt, Astrid
    Aloj, Luigi
    Wong, Jeffrey
    Djaileb, Loic
    Pathak, Dhrubajyoti
    Liu, Yongmin
    Solnes, Lilja
    CANCER RESEARCH, 2024, 84 (07)
  • [35] Synthesis and Evaluation of 68Ga- and 177Lu-Labeled [Pro14]bombesin(8-14) Derivatives for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer
    Wang, Lei
    Kuo, Hsiou-Ting
    Chapple, Devon E.
    Chen, Chao-Cheng
    Kurkowska, Sara
    Colpo, Nadine
    Uribe, Carlos
    Benard, Francois
    Lin, Kuo-Shyan
    MOLECULAR PHARMACEUTICS, 2024, 21 (12) : 6385 - 6397
  • [36] Synthesis and Evaluation of 68Ga- and 177Lu-Labeled [diF-Pro14]Bombesin(6-14) Analogs for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer
    Wang, Lei
    Chen, Chao-Cheng
    Chapple, Devon
    Wong, Antonio A. W. L.
    Kurkowska, Sara
    Lau, Wing Sum
    Uribe, Carlos F.
    Benard, Francois
    Lin, Kuo-Shyan
    PHARMACEUTICALS, 2025, 18 (02)
  • [37] Organ-specific response to [177Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [68Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors
    Bessac, Darejan Mamulashvili
    Baltzinger, Philippe
    Poterszman, Nathan
    Van, Floriane Pham
    Collen, Cedric
    Malouf, Gabriel G.
    Ouvrard, Eric
    Kaseb, Ashjan
    Porot, Clemence
    Ben Abdelghani, Meher
    Addeo, Pietro
    Mertz, Luc
    Goichot, Bernard
    Imperiale, Alessio
    ENDOCRINE, 2025, 87 (03) : 1333 - 1341
  • [38] AUTOMATED SYNTHESIS FOR THE PREPARATION OF 68Ga/177Lu-LABELLED PEPTIDE (DOTATATE) FOR SOMATOSTATIN RECEPTOR POSITIVE TUMOUR DIAGNOSIS AND TREATMENT-THE LIVERPOOL HOSPITAL EXPERIENCE
    Kumar, Divesh
    Som, Seu
    Lin, Peter
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 13 - 13
  • [39] Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors
    Noritoshi Kobayashi
    Shoko Takano
    Kenichi Ito
    Madoka Sugiura
    Matsuyoshi Ogawa
    Yuma Takeda
    Naoki Okubo
    Akihiro Suzuki
    Motohiko Tokuhisa
    Tomohiro Kaneta
    Daisuke Utsunomiya
    Masaharu Hata
    Tomio Inoue
    Makoto Hosono
    Seigo Kinuya
    Yasushi Ichikawa
    Annals of Nuclear Medicine, 2021, 35 : 1332 - 1341
  • [40] Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors
    Kobayashi, Noritoshi
    Takano, Shoko
    Ito, Kenichi
    Sugiura, Madoka
    Ogawa, Matsuyoshi
    Takeda, Yuma
    Okubo, Naoki
    Suzuki, Akihiro
    Tokuhisa, Motohiko
    Kaneta, Tomohiro
    Utsunomiya, Daisuke
    Hata, Masaharu
    Inoue, Tomio
    Hosono, Makoto
    Kinuya, Seigo
    Ichikawa, Yasushi
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (12) : 1332 - 1341
12345